SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001062993-22-022769
Filing Date
2022-11-25
Accepted
2022-11-25 09:11:34
Documents
1
Effectiveness Date
2022-11-25
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8000
  Complete submission text file 0001062993-22-022769.txt   9139
Mailing Address 4 KING STREET WEST, SUITE 401 TORONTO A6 M5H 1B6
Business Address 4 KING STREET WEST, SUITE 401 TORONTO A6 M5H 1B6 6478467766
Thiogenesis Therapeutics, Corp. (Filer) CIK: 0001877778 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0228
Type: D | Act: 33 | File No.: 021-465814 | Film No.: 221418030